MedTrace Logo

Neuromodulation in MS Using Translingual Stimulation

NCT05275049 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 52

Last updated 2022-03-11

No results posted yet for this study

Summary

The overarching aim of this study is to examine if there is additional benefit to adding trans-lingual electrical stimulation to physiotherapy aimed at improving walking and balance in people with multiple sclerosis (MS).

Conditions

Interventions

COMBINATION_PRODUCT

PT plus translingual stimulation device

PoNS device will be used to deliver trans-lingual electrical stimulation. The stimulation will be delivered while the participants engages in evidence-based physiotherapy for walking and balance.

COMBINATION_PRODUCT

PT plus translingual stimulation control device

Control device will be used. Participants will wear device while engaging in evidence-based physiotherapy for walking and balance.

Sponsors & Collaborators

  • Memorial University of Newfoundland

    collaborator OTHER

  • University of Saskatchewan

    lead OTHER

Principal Investigators

  • Sarah Donkers · University of Saskatchewan

  • Michelle Ploughman · Memorial University of Newfoundland

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-07-05
Primary Completion
2022-07-05
Completion
2022-12-01
FDA Device
Yes

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05275049 on ClinicalTrials.gov